
Join to view full profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-8964
Dr. Karp is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1972 - 1974
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1971 - 1972
Stanford University School of MedicineClass of 1971
Certifications & Licensure
MD State Medical License 1975 - 2016
Clinical Trials
Publications & Presentations
PubMed
- A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid Leukemias.Bryan Chan, Eesha Balar, Seiichi Villalona, Judith Karp, Allison Leahy
Hematology Reports. 2026-02-06 - 1 citationsGenomic testing and patient rights.C Michael Jones, Judith Karp, Dena S Davis
Journal of the National Cancer Institute. 2024-05-08 - 9 citationsSystematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia.Stephanie Franco, Xue Geng, Valeriy Korostyshevskiy, Judith E Karp, Catherine Lai
Cancer. 2023-10-01
Journal Articles
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Ri...Joshua F Zeidner, Mark R Litzow, Jeffrey E Lancet, Prithviraj Bose, Raoul Tibes, Ivana Gojo, Richard F Little, Judith E Karp, Leukemia Research
Authored Content
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Risk Acute Myeloid Leukemia (AML)August 2018
Press Mentions
Improving Transparency in Phase 1 Clinical TrialsFebruary 9th, 2023
Rana R. McKay, MD: Developing Clinical Trials to Answer Questions Raised in PracticeApril 20th, 2022
Judith Esther Karp, MD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's WhoDecember 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









